Interline Therapeutics is a pharmaceutical discovery company with a primary focus on systematically understanding protein communities to define the molecular mechanisms of diseases. Traditionally, proteins have been examined in isolation, yet they operate within interconnected networks of dynamic protein interactions in nature. The limited understanding of how these networks influence common diseases has constrained medical researchers. Interline is in the process of developing a precision medicine platform to chart and regulate protein communities, capitalizing on recent progress in genomics, proteomics, structural biology, and computational chemistry.